Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.33% Brimonidine in Persistent Erythema of Rosacea
NCT07431476Phase 4Completed
- Sponsor
- Istanbul Education Research Hospital
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine transdermal lotion in rosacea, sponsored by Istanbul Education Research Hospital. Started May 2025; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT07431476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07431476.